- The study investigates the impact of intravitreal aflibercept (IVA) on retinal vessel diameters in patients with neovascular age-related macular degeneration (AMD), focusing on 15 eyes from 15 treatment-naive patients.
- After receiving monthly IVA injections for three months, patients demonstrated significant retinal arteriolar vasoconstriction and improvements in best-corrected visual acuity (BCVA), as well as reductions in central macular thickness (CMT) and choroidal thickness.
- Control eyes showed no significant changes, indicating that the observed effects were specifically linked to the IVA treatment.